DK2686421T3 - Generering af nk-celler og nk-celleforløbere - Google Patents

Generering af nk-celler og nk-celleforløbere Download PDF

Info

Publication number
DK2686421T3
DK2686421T3 DK12711984.0T DK12711984T DK2686421T3 DK 2686421 T3 DK2686421 T3 DK 2686421T3 DK 12711984 T DK12711984 T DK 12711984T DK 2686421 T3 DK2686421 T3 DK 2686421T3
Authority
DK
Denmark
Prior art keywords
cells
generation
cell procedures
procedures
cell
Prior art date
Application number
DK12711984.0T
Other languages
English (en)
Inventor
Jan Spanholtz
Harmen Dolstra
Original Assignee
Glycostem Therapeutics B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycostem Therapeutics B V filed Critical Glycostem Therapeutics B V
Application granted granted Critical
Publication of DK2686421T3 publication Critical patent/DK2686421T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0646Natural killers cells [NK], NKT cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/125Stem cell factor [SCF], c-kit ligand [KL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/145Thrombopoietin [TPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/21Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/22Colony stimulating factors (G-CSF, GM-CSF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2302Interleukin-2 (IL-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2306Interleukin-6 (IL-6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2307Interleukin-7 (IL-7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2315Interleukin-15 (IL-15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/235Leukemia inhibitory factor [LIF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/26Flt-3 ligand (CD135L, flk-2 ligand)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90Polysaccharides
    • C12N2501/91Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK12711984.0T 2011-03-18 2012-03-16 Generering af nk-celler og nk-celleforløbere DK2686421T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2011050193 2011-03-18
EP11162866 2011-04-18
PCT/NL2012/050165 WO2012128622A1 (en) 2011-03-18 2012-03-16 Generation of nk cells and nk-cell progenitors

Publications (1)

Publication Number Publication Date
DK2686421T3 true DK2686421T3 (da) 2021-03-08

Family

ID=45928983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12711984.0T DK2686421T3 (da) 2011-03-18 2012-03-16 Generering af nk-celler og nk-celleforløbere

Country Status (7)

Country Link
US (1) US11118165B2 (da)
EP (1) EP2686421B1 (da)
CA (1) CA2830080C (da)
DK (1) DK2686421T3 (da)
ES (1) ES2856825T3 (da)
PL (1) PL2686421T3 (da)
WO (1) WO2012128622A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134113A (zh) * 2012-08-13 2022-03-04 人类起源公司 自然杀伤细胞及其用途
US9763983B2 (en) 2013-02-05 2017-09-19 Anthrogenesis Corporation Natural killer cells from placenta
CN104509529A (zh) * 2013-10-08 2015-04-15 康克韦斯特公司 用于储存和运输nk-92细胞系的方案和培养基
WO2015054299A1 (en) * 2013-10-08 2015-04-16 Conkwest, Inc. Protocol and media for storage and transport of nk-92 cell line
KR101697473B1 (ko) 2014-11-26 2017-01-18 주식회사 녹십자랩셀 T 세포를 이용한 자연살해세포의 배양방법
IL258666B2 (en) * 2015-10-15 2024-09-01 Celularity Inc Natural killer cells and ILC3 cells and their use
US20190032013A1 (en) * 2016-01-29 2019-01-31 Tract Therapeutics, Inc. Immune cell selection, expansion, and use
JP2019519486A (ja) 2016-05-07 2019-07-11 セルラリティ インコーポレイテッド ナチュラルキラー細胞を使用して急性骨髄性白血病および多発性骨髄腫を処置する方法
GB201703476D0 (en) 2017-03-03 2017-04-19 Imp Innovations Ltd Natural killer cells
GB201704953D0 (en) 2017-03-28 2017-05-10 Imp Innovations Ltd Natural killer cells
JP6647240B2 (ja) 2017-05-12 2020-02-14 米満 吉和 高活性nk細胞、およびその利用
EP3633029A4 (en) 2017-05-26 2021-06-09 Green Cross Lab Cell Corporation METHOD OF DEVELOPING A NATURAL KILLER CELL USING A T-CELL
US11446329B2 (en) * 2017-11-01 2022-09-20 Restem Llc Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
KR102265437B1 (ko) * 2017-11-24 2021-06-15 의료법인 성광의료재단 Nk 배양용 조성물 및 이를 이용하여 nk 세포를 배양하는 방법
CA3089853A1 (en) 2018-02-01 2019-08-08 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
CN108315299A (zh) * 2018-02-13 2018-07-24 南京支云松生物科技有限公司 一种即用型异体nk细胞库网络储运应用系统
WO2019182392A1 (ko) * 2018-03-23 2019-09-26 주식회사 녹십자랩셀 자연살해세포의 제조방법
GB201810486D0 (en) 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells
CN113383069B (zh) 2018-11-14 2024-12-13 Gc细胞治疗 使用转化的t细胞培养脐带血来源的自然杀伤细胞的方法
AU2019456283B2 (en) 2019-07-08 2023-06-08 Immunitybio, Inc. Mononuclear cell derived NK cells
US11453862B2 (en) 2019-07-08 2022-09-27 Immunitybio, Inc. Mononuclear cell derived NK cells
WO2021015615A1 (en) * 2019-07-22 2021-01-28 Glycostem Therapeutics B.V. Low density cell culture
EP4032972A4 (en) * 2019-09-18 2024-07-24 Slbigen Inc. GENETICALLY MODIFIED NK CELL LINE TRANSDUCED WITH A GENE ENCODING A NEW CHIMERIC ANTIGEN RECEPTOR AND ITS USE
EP4114415A1 (en) 2020-03-06 2023-01-11 Sorrento Therapeutics, Inc. Innate immunity killer cells targeting psma positive tumor cells
CN111286488B (zh) * 2020-03-10 2021-04-02 河南侨创生命科技有限公司 一种自然杀伤细胞体外培养方法
US11547726B2 (en) * 2020-03-26 2023-01-10 Honed Life Sciences, Llc Enhancement of production of NK cells from stem cells
US12236422B2 (en) * 2022-01-05 2025-02-25 Mastercard International Incorporated Computer-implemented methods and systems for authentic user-merchant association and services
GB202217507D0 (en) * 2022-11-23 2023-01-04 Imperial College Innovations Ltd Natural killer cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1941027B1 (en) * 2005-09-28 2014-08-20 IPD-Therapeutics B.V. Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics.
CN101506356A (zh) * 2006-08-23 2009-08-12 比内克斯有限公司 用于免疫治疗的活化淋巴细胞的制备方法
PL2142642T3 (pl) * 2007-03-27 2017-10-31 Ipd Therapeutics B V Sposoby i środki do proliferacji komórek macierzystych oraz następczego wytwarzania i ekspansji komórek progenitorowych, jak również wytwarzania komórek efektorowych jako leków klinicznych
CA2785627C (en) 2009-12-29 2020-02-18 Gamida-Cell Ltd. Methods for enhancing natural killer cell proliferation and activity
AU2010347018A1 (en) * 2010-02-24 2012-09-20 Ingo Schmidt-Wolf Method for the generation of a CIK cell and NK cell population
KR20180086204A (ko) 2015-11-05 2018-07-30 글리코스템 떼라퓨틱스 비.브이. 면역치료법에 사용하기 위한 조성물

Also Published As

Publication number Publication date
WO2012128622A1 (en) 2012-09-27
ES2856825T3 (es) 2021-09-28
EP2686421A1 (en) 2014-01-22
CA2830080C (en) 2021-10-26
US20140080148A1 (en) 2014-03-20
EP2686421B1 (en) 2020-12-23
US11118165B2 (en) 2021-09-14
PL2686421T3 (pl) 2021-05-31
CA2830080A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
DK2686421T3 (da) Generering af nk-celler og nk-celleforløbere
PL2785359T3 (pl) Mezenchymalne komórki zrębowe i związane z nimi zastosowania
EP2757591A4 (en) Solar cell module
EP2780952A4 (en) INTELLIGENT PV CELLS AND PV MODULES
EP2727147A4 (en) MEMORY CELL STRUCTURES
DK3546569T3 (da) Terapeutiske midler med anvendelse af fedtceller og cellesekreter
EP2530737A4 (en) SOLAR CELL MODULE
EP2411507A4 (en) EXPANSION OF NK CELLS
EP2637015A4 (en) cell analyzer
DK2837680T3 (da) Mammaliacellekultur
DK3260140T3 (da) Fremgangsmåder og produkter til transficering af celler
EP2850675A4 (en) ELECTROCHEMICAL CELLS AND METHOD FOR THE PRODUCTION THEREOF
EP2839502A4 (en) INTEGRATED THIN-FILM SOLAR CELL CONNECTION
PL2668680T3 (pl) Przezroczyste ogniwa fotowoltaiczne
DK2923400T3 (da) Reduktion af gasning i lithiumtitanatceller
EP3719852C0 (en) SOLAR CELL
EP2557610A4 (en) Cell module
EP2626910A4 (en) PHOTOVOLTAIC CELL
DK2548256T3 (da) Elektrokemisk cellestak
EP2590226A4 (en) SOLAR CELL MODULE
EP2805350A4 (en) STORAGE CELLS AND METHOD FOR MANUFACTURING THESE STORAGE CELLS
EP2722386A4 (en) CRUSHED CELLS AND COMPOSITION THEREOF
EP2731147A4 (en) SOLAR CELL MODULE AND SOLAR CELL
EP2710651A4 (en) ELECTROCHEMICAL CELLS WITH POLYIMIDES
EP2433312A4 (en) SOLAR TRANSPORT